Search

Why people with sight loss can experience visual hallucinations

Why do some people with vision loss experience hallucinations, while others do not?

How clinical trials help improve treatments

What are clinical trials? How do they work and what role do they play in improving healthcare? Geraldine Hoad and Sarah Clinton from the Macular Society’s research team join us to discuss the types of trials currently taking place in the UK and how you could get involved.

What is a genetic counsellor and what genetic tests are available?

Elena Schiff is a genetic counsellor at Moorfields Eye Hospital and joins us to discuss what a genetic counsellor does, the chances of inheriting macular disease and the different genetic tests available.

What role do CVIs play when seeking support for sight loss?

A Certificate of Visual Impairment (CVI) can play an important role in ensuring people with sight loss receive the support they need. It can open up access to practical, financial, and emotional support, while also providing data to improve eye health services across the UK.

Discover how a new implant has enabled patients with dry age-related macular degeneration to read again.

With over 84% of trial participants regaining the ability to read letters, numbers, and words. Mahi Muqit, senior vitreoretinal consultant at Moorfields Eye Hospital and the Institute of Ophthalmology at UCL, joins our webinar to discuss the groundbreaking results from the PRIMA system clinical trial.

Professor Rachael Pearson and her team have been working on furthering our understanding of what genes are instrumental in the development of the macula. Understanding how the macula is made is key in identifying what can go wrong and gives clues to effective treatment strategies.

Elena Piotter, a PhD student at the University of Oxford, shares an update on her project which has been exploring treating Stargardt disease using the gene-editing technique called CRISPR.

Dr Katie Curran and professor Tunde Peto discuss as new trial which will explore whether L-DOPA, a medicine which has been used to treat patients with Parkinson’s disease for several years, could help people living with wet age-related macular degeneration (AMD).

Dr Agata Rozanska from Newcastle University discusses her research which is using cells from patients to build a simple lab model that copies key features of age-related macular degeneration (AMD).

Professor Andrew Dick from the University of Bristol joined us to update on his Macular Society funded project where researchers have been exploring ways to help keep mitochondria healthy.